Research & Development



  曹襄打了一個哆嗦,他又想起在那個春光明媚的日子里,何愁有掀開一塊綢布,指著盤子里放著的整整齊齊的尸塊對他們道︰“看啊,這就是不听話的下場!”   大漢自己本身就是一個物資極度匱乏的地方,我們的糧食養活自己人都不夠,我們的鹽巴都是從海邊運過來的,我們的鐵器價格在大漢就居高不下。俺来射   衛良小聲道︰“是軍司馬安排的。”俺来撸   就在此時,鏡鐵山礦區濃煙四起,殺聲四起,存留在礦區的漢奴們,也在同一時間暴動,他們用鐵錘,用鋤頭,用叉子,鐵棍,木棒用所有能用的武器,向昔日殘害他們的匈奴監工發起進攻。   他剛剛掬起一捧水,卻被他的親兵霍壽給打掉了。俺要撸   或許是過于疲憊的原因,霍去病,趙破奴,李敢在心情徹底放松之後就很快的倒在城頭睡著了。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo